We've already run into some domestic production issues; but I don't think that there was ever any real expectation that we would be taking AZ from the EU once they were at scale and using them internally. We're still investing in other UK facilities for production both of AZ and other vaccines that look like they will be approved.TheNatalShark wrote: ↑Fri Jan 29, 2021 11:49 amNot a lawyer or even enjoy reading contracts, so won't pretend to add anything of value.Saint wrote: ↑Fri Jan 29, 2021 11:24 amAll comes down to how you read 5.4TheNatalShark wrote: ↑Fri Jan 29, 2021 11:15 am EU - AZ contract published now, for all the speculation
https://ec.europa.eu/commission/pressco ... /ip_21_302
The EU obviously believe that that article entitles them to a share of vaccines produced in the UK. My read is that it allows AZ to supply the EU from UK factories without the need to inform the EU of source (whereas production from outside the EU requires EU agreement)
I'm just concerned that the aggressive stance the EU appears to have taken may result in impact of UK deliveries, whether justified or not, as it will likely be used as a comparative as to what AZ's best efforts actually entailed.
If we run into domestic production issues and need amicable solution with European production...
The real risk is with the EU threatening to withhold Pfizer; we could choose to be real shits with them then and withold the component manufactured only in East Yorkshire, but then this really would start spiralling out of control. For all of the EU complaining taht AZ is undershooting their deliveries, tehy;re also undershooting our deliuveries as well (by quite a lot now). Thems the risks when it comes to trying to work out how to scale an organic production process that;s not been used before.
Note that the REAL experts in this out in India have got it cracked - but they do this stuff at huge scale.